doi: 10.1007/BF02779300.
The prevalence of anti-HCV antibodies in hemodialysis patients
Affiliations
- PMID: 1909269
- DOI: 10.1007/BF02779300
Item in Clipboard
The prevalence of anti-HCV antibodies in hemodialysis patients
Gastroenterol Jpn.
1991 Jul.
Abstract
The prevalence of antibodies to hepatitis C virus (anti-HCV) was assessed in 489 hemodialysis patients and 152 members of the staff of dialysis units, using an Ortho HCV Ab ELISA Test. Of the 489 patients, 100 (20.4%) had anti-HCV, a significantly greater rate than was found in either staff members (0.7%, P less than 0.01) or local healthy blood donors (1.1%, P less than 0.001). Anti-HCV positivity was apparently related to the duration of hemodialysis.
Similar articles
-
Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.Hepatogastroenterology. 1992 Apr;39(2):161-5. Hepatogastroenterology. 1992. PMID: 1378811
-
Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.Nephron. 1992;61(3):346. doi: 10.1159/000186936. Nephron. 1992. PMID: 1323786
-
Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.Hepatogastroenterology. 1995 Apr;42(2):162-5. Hepatogastroenterology. 1995. PMID: 7545641
-
Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.FEMS Microbiol Rev. 1994 Jul;14(3):253-8. doi: 10.1111/j.1574-6976.1994.tb00096.x. FEMS Microbiol Rev. 1994. PMID: 7522023 Review.
-
Recent advances in the management of hepatitis C in the dialysis population.Int J Artif Organs. 2002 Jun;25(6):503-11. doi: 10.1177/039139880202500604. Int J Artif Organs. 2002. PMID: 12117289 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Medical